PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2014.2492015474607-615Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid TumorsDo-Youn Oh, Se-Hoon Lee, Sae-Won Han, Mi-Jung Kim, Tae-Min Kim, Tae-You Kim, Dae Seog Heo, Miyuki Yuasa, Yasuo Yanagihara, Yung-Jue Banghttp://e-crt.org/upload/pdf/crt-2014-249.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2014.249, http://www.e-crt.org/upload/pdf/crt-2014-249.pdf
Cancer Chemotherapy and Pharmacology10.1007/s00280-014-2480-22014741125-130Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumorsJohanna C. Bendell, David S. Hong, Howard A. Burris, Aung Naing, Suzanne F. Jones, Gerald Falchook, Patricia Bricmont, Agnes Elekes, Edwin P. Rock, Razelle Kurzrockhttp://link.springer.com/content/pdf/10.1007/s00280-014-2480-2.pdf, http://link.springer.com/article/10.1007/s00280-014-2480-2/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00280-014-2480-2, http://link.springer.com/content/pdf/10.1007/s00280-014-2480-2.pdf
Hepatology Research10.1111/hepr.12504201545131283-1291Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinomaTakuji Okusaka, Hideki Ueno, Masafumi Ikeda, Shuichi Mitsunaga, Masato Ozaka, Hiroshi Ishii, Osamu Yokosuka, Yoshihiko Ooka, Ryo Yoshimoto, Yasuo Yanagihara, Kiwamu Okitahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fhepr.12504, http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12504/fullpdf
Cancer Research and Treatment10.4143/crt.2018.2262019512510-518Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular CarcinomaChanghoon Yoo, Jihoon Kang, Ho Yeong Lim, Jee Hyun Kim, Myung-Ah Lee, Kyung-Hun Lee, Tae-You Kim, Baek-Yeol Ryoohttp://e-crt.org/upload/pdf/crt-2018-226.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2018.226, http://www.e-crt.org/upload/pdf/crt-2018-226.pdf
European Journal of Cancer Supplements10.1016/s1359-6349(05)81739-22005324191448 ORAL Molecular pharmacodynamic (MPD) phase I study with serial tumor and skin biopsies of the oral mTOR inhibitor Everolimus (E, RAD001) at different doses and schedules in patients (pts) with advanced solid tumorshttps://api.elsevier.com/content/article/PII:S1359634905817392?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634905817392?httpAccept=text/plain
Radiotherapy and Oncology10.1016/s0167-8140(04)82105-4200473S108238 oral Phase I study of combined treatment with the oral alkyl-phospholipid (APL) perifosine and radiation in patients with advanced solid tumorshttps://api.elsevier.com/content/article/PII:S0167814004821054?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0167814004821054?httpAccept=text/plain
European Journal of Cancer10.1016/s0959-8049(02)80825-5200238S56A phase I and pharmacokinetic study of the farnesyl transferase inhibitor, CP-609,754 in patients with advanced solid tumorshttps://api.elsevier.com/content/article/PII:S0959804902808255?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0959804902808255?httpAccept=text/plain
Annals of Oncology10.1093/annonc/mdw521.056201627vii87-vii88Phase I study of roniciclib (BAY1000394), an oral CDK inhibitor in Japanese patients with advanced solid tumorsTakashi Seto, Kaname Nosaki, Gen Shinoda, Kensei Hashizume, Iku Yamaguchi, Jun Tsuburaya, Hendrik Nogai, Kohei Shitara, Kiyotaka Yohhttps://api.elsevier.com/content/article/PII:S0923753419538881?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419538881?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/27/suppl_7/mdw521.056/22971638/mdw521.056.pdf
Investigational New Drugs10.1007/s10637-019-00859-420193841175-1185Phase I study of TAS-115, a novel oral multi-kinase inhibitor, in patients with advanced solid tumorsToshihiko Doi, Nobuaki Matsubara, Akira Kawai, Norifumi Naka, Shunji Takahashi, Hiroji Uemura, Noboru Yamamotohttps://link.springer.com/content/pdf/10.1007/s10637-019-00859-4.pdf, https://link.springer.com/article/10.1007/s10637-019-00859-4/fulltext.html, https://link.springer.com/content/pdf/10.1007/s10637-019-00859-4.pdf
Annals of Oncology10.1016/s0923-7534(20)33060-x201223ix154Phase I Dose-Escalation Study of Oral Selective C-Met Inhibitor Emd 1214063 in Patients with Advanced Solid TumorsG.S. Falchook, D.S. Hong, H.M. Amin, S. Fu, S.A. Piha-Paul, M.B. Klevesath, V. Jego, A. Johne, S. Stinchi, R. Kurzrockhttps://api.elsevier.com/content/article/PII:S092375342033060X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S092375342033060X?httpAccept=text/plain